HUNTINGTON NATIONAL BANK - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$44,955
+11.3%
2,906
+13.0%
0.00%
Q2 2023$40,406
-2.6%
2,572
+2.1%
0.00%
Q1 2023$41,496
-31.1%
2,518
-34.7%
0.00%
-100.0%
Q4 2022$60,201
+62.7%
3,859
+36.1%
0.00%
Q3 2022$37,000
-7.5%
2,8360.0%0.00%
Q2 2022$40,000
-32.2%
2,836
-31.3%
0.00%
-100.0%
Q1 2022$59,000
+51.3%
4,126
+45.5%
0.00%
Q4 2021$39,000
-15.2%
2,836
+0.0%
0.00%
Q3 2021$46,000
-16.4%
2,835
-13.5%
0.00%
-100.0%
Q2 2021$55,000
+19.6%
3,276
+30.2%
0.00%0.0%
Q1 2021$46,0000.0%2,5170.0%0.00%0.0%
Q4 2020$46,000
+2.2%
2,5170.0%0.00%0.0%
Q3 2020$45,0000.0%2,5170.0%0.00%0.0%
Q2 2020$45,000
-48.9%
2,517
-56.4%
0.00%
-50.0%
Q1 2020$88,000
-30.2%
5,772
-10.2%
0.00%0.0%
Q4 2019$126,000
+93.8%
6,427
+68.1%
0.00%
+100.0%
Q3 2019$65,000
-42.0%
3,824
-39.4%
0.00%
-50.0%
Q2 2019$112,000
-16.4%
6,307
-4.3%
0.00%0.0%
Q1 2019$134,0006,5870.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders